JP2014532655A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014532655A5 JP2014532655A5 JP2014539026A JP2014539026A JP2014532655A5 JP 2014532655 A5 JP2014532655 A5 JP 2014532655A5 JP 2014539026 A JP2014539026 A JP 2014539026A JP 2014539026 A JP2014539026 A JP 2014539026A JP 2014532655 A5 JP2014532655 A5 JP 2014532655A5
- Authority
- JP
- Japan
- Prior art keywords
- acoustic energy
- nanosuspension
- frequency
- hertz
- prepared according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 19
- 239000006070 nanosuspension Substances 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000002105 nanoparticle Substances 0.000 claims 3
- 239000002612 dispersion medium Substances 0.000 claims 2
- 239000002609 medium Substances 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161553508P | 2011-10-31 | 2011-10-31 | |
| US61/553,508 | 2011-10-31 | ||
| PCT/US2012/062026 WO2013066735A1 (en) | 2011-10-31 | 2012-10-26 | Nano-suspension process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014532655A JP2014532655A (ja) | 2014-12-08 |
| JP2014532655A5 true JP2014532655A5 (https=) | 2015-11-19 |
Family
ID=48192642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014539026A Pending JP2014532655A (ja) | 2011-10-31 | 2012-10-26 | ナノ懸濁過程 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9381518B2 (https=) |
| EP (1) | EP2773323A4 (https=) |
| JP (1) | JP2014532655A (https=) |
| AU (1) | AU2012332894A1 (https=) |
| CA (1) | CA2853470A1 (https=) |
| WO (1) | WO2013066735A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3082708B1 (en) * | 2013-12-17 | 2019-04-03 | Merck Sharp & Dohme Corp. | Media milling process for the manufacture of active pharmaceutical ingredients in propellants |
| WO2017087897A1 (en) * | 2015-11-18 | 2017-05-26 | Arytha Biosciences, Llc | Processes and systems for preparing cellular or viral membranes and nanoparticles |
| JP6667651B2 (ja) * | 2016-09-30 | 2020-03-18 | 富士フイルム株式会社 | 分散物の製造方法、及びインクジェット記録方法 |
| US11344496B2 (en) * | 2017-08-25 | 2022-05-31 | Merck Sharp & Dohme Corp. | Methods for preparing stabilized amorphous drug formulations using acoustic fusion |
| US12285731B2 (en) | 2019-09-12 | 2025-04-29 | United States Of America, As Represented By The Secretary Of The Army | Acoustic mixing system for creating propellant mixture |
| WO2025096329A1 (en) * | 2023-10-31 | 2025-05-08 | Genentech, Inc. | Method for preparing stable peptide nanoparticle formulations |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5552160A (en) * | 1991-01-25 | 1996-09-03 | Nanosystems L.L.C. | Surface modified NSAID nanoparticles |
| US5591456A (en) * | 1995-02-10 | 1997-01-07 | Nanosystems L.L.C. | Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer |
| RU2186562C2 (ru) * | 1996-08-22 | 2002-08-10 | Ресеч Трайангл Фармасьютикалс Лтд. | Композиции, представляющие собой микрочастицы веществ, нерастворимых в воде, и способ их изготовления |
| GB2369308B (en) * | 1998-07-22 | 2002-11-06 | Protasis Uk Ltd | Particle manipulation device |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
| AU2003263024A1 (en) * | 2002-04-23 | 2003-11-10 | Christopher Mcconville | Process of forming and modifying particles and compositions produced thereby |
| GB0216700D0 (en) * | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
| US7188993B1 (en) * | 2003-01-27 | 2007-03-13 | Harold W Howe | Apparatus and method for resonant-vibratory mixing |
| GB0302671D0 (en) | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
| US20060086834A1 (en) | 2003-07-29 | 2006-04-27 | Robert Pfeffer | System and method for nanoparticle and nanoagglomerate fluidization |
| US7541166B2 (en) * | 2003-09-19 | 2009-06-02 | Microfluidic Systems, Inc. | Sonication to selectively lyse different cell types |
| AU2005295269B2 (en) | 2004-10-19 | 2010-05-13 | Regeneron Pharmaceuticals, Inc. | Method for generating an animal homozygous for a genetic modification |
| AU2005304952B2 (en) * | 2004-11-08 | 2013-04-04 | Baxter Healthcare S.A. | Nanoparticulate compositions of tubulin inhibitors |
| US20060134646A1 (en) | 2004-12-17 | 2006-06-22 | Ansari Aftab A | Method for treatment of HIV infection |
| US7776360B2 (en) | 2004-12-21 | 2010-08-17 | Baxter International | (Polyalkoxy)sulfonate surface modifiers |
| CA2603189A1 (en) * | 2005-04-13 | 2006-10-19 | Pfizer Products Inc. | Injectable depot formulations and methods for providing sustained release of poorly soluble drugs comprising nanoparticles |
| DE102005057333B4 (de) * | 2005-11-28 | 2008-11-20 | Dr. Hielscher Gmbh | Verfahren und Vorrichtungen zur Beschallung von Flüssigkeiten mit Niederfrequenz-Leistungs-Ultraschall |
| US20110163469A1 (en) * | 2005-12-16 | 2011-07-07 | Massachusetts Institute Of Technology | High-throughput fabrication of microparticles |
| US20080033296A1 (en) * | 2006-02-17 | 2008-02-07 | Florida Gulf Coast University | Methods for delivering materials into biological systems using sonic energy |
| EP2178893A4 (en) * | 2007-07-16 | 2012-09-19 | Poniard Pharmaceuticals Inc | ORAL FORMULATIONS FOR PICOPLATIN |
| EP2262898B1 (en) | 2008-03-07 | 2018-01-24 | Regeneron Pharmaceuticals, Inc. | Es cell-derived mice from diploid host embryo injection |
| US20110223216A1 (en) * | 2008-11-17 | 2011-09-15 | Wayne State University | Nanoparticles and Porous Particles and Methods of Making the Same |
-
2012
- 2012-10-26 EP EP12846357.7A patent/EP2773323A4/en not_active Withdrawn
- 2012-10-26 WO PCT/US2012/062026 patent/WO2013066735A1/en not_active Ceased
- 2012-10-26 JP JP2014539026A patent/JP2014532655A/ja active Pending
- 2012-10-26 CA CA2853470A patent/CA2853470A1/en not_active Abandoned
- 2012-10-26 US US14/354,187 patent/US9381518B2/en active Active
- 2012-10-26 AU AU2012332894A patent/AU2012332894A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014532655A5 (https=) | ||
| Paudel et al. | Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations | |
| Thorat et al. | Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: Recent developments and future perspective | |
| Bell et al. | Advances in integrative nanomedicine for improving infectious disease treatment in public health | |
| AU2018253545A1 (en) | Microcrystalline diketopiperazine compositions and methods | |
| WO2014014613A3 (en) | Self-assembling peptides, peptide nanostructures and uses thereof | |
| WO2015152693A3 (ko) | 신규 이중 나선 올리고 rna 및 이를 포함하는 섬유증 또는 호흡기 질환의 예방 또는 치료용 약학조성물 | |
| MY207375A (en) | Finasteride polymeric nanoparticle, aqueous suspension containing the same, composition for the treatment of alopecia, process of preparation of said composition, and its use | |
| Floris et al. | Cavitation effect on chitosan nanoparticle size: A possible approach to protect drugs from ultrasonic stress | |
| WO2013132457A3 (en) | Nanocrystalline solid dispersion compositions and process of preparation thereof | |
| Zhu et al. | The induction of maturation on dendritic cells by TiO2 and Fe3O4@ TiO2 nanoparticles via NF-κB signaling pathway | |
| WO2019090030A8 (en) | Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations | |
| CA2751625C (en) | Device and method for producing pharmaceutically highly refined particles and for coating said particles in microreactors | |
| WO2014152782A3 (en) | Substantially surfactant-free, submicron dispersions of hydrophobic agents containing high levels of water miscible solvent | |
| CN103653179A (zh) | 一种肉桂精油纳米脂质体及其制备方法 | |
| UA112540C2 (uk) | Плівкова лікарська форма, яка містить вільну основу силденафілу, і спосіб її отримання | |
| JP2013047264A5 (https=) | ||
| WO2015053857A3 (en) | Efficient collection of nanoparticles | |
| RU2014148544A (ru) | Составы на основе полиинозиновой-полицитидиловой кислоты (poly(i:с)) для лечения инфекций верхних дыхательных путей | |
| CY1124635T1 (el) | Ξηρες φαρμακευτικες συνθεσεις που περιεχουν νανοσωματιδια ενεργου παραγοντα δεσμευμενα σε σωματιδια φορεα | |
| WO2017103600A8 (en) | Preparation of respirable zafirlukast particles | |
| Tomoiaga et al. | Investigations on nanoconfinement of low-molecular antineoplastic agents into biocompatible magnetic matrices for drug targeting | |
| WO2013025442A3 (en) | Concentrated felbamate formulations for parenteral administration | |
| WO2017036916A8 (en) | Process to manufacture cross-linked enzyme aggregates | |
| Teng et al. | A facile way for fabricating PEGylated hollow mesoporous silica nanoparticles and their drug delivery application |